These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 10765934)

  • 41. [Anti-U1RNP antibodies and lupus nephritis].
    Ilić T; Curić S; Vodopivec S; Mitić I; Durdević-Mirković T; Sakac V; Lenert P
    Med Pregl; 2000; 53(11-12):589-94. PubMed ID: 11320745
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Immunologic tests: Anti-RNP . Sm antibodies (anti-U1 RNP antibodies)].
    Kaburaki J
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():483-5. PubMed ID: 16111308
    [No Abstract]   [Full Text] [Related]  

  • 43. [The clinical significance of anti-ENA antibodies and anticentromere antibody (ACA) in patients with sclerodermatous skin changes and Raynaud's phenomenon].
    Uchida K; Kondo H; Kashiwazaki S
    Ryumachi; 1984 Aug; 24(4):241-9. PubMed ID: 6334895
    [No Abstract]   [Full Text] [Related]  

  • 44. The U1-snRNP complex: structural properties relating to autoimmune pathogenesis in rheumatic diseases.
    Kattah NH; Kattah MG; Utz PJ
    Immunol Rev; 2010 Jan; 233(1):126-45. PubMed ID: 20192997
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases.
    Santoro P; De Andrea M; Migliaretti G; Trapani C; Landolfo S; Gariglio M
    J Rheumatol; 2002 Jan; 29(1):90-3. PubMed ID: 11824977
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus.
    Simon D; Czömpöly T; Berki T; Minier T; Peti A; Tóth E; Czirják L; Németh P
    Int Immunol; 2009 Apr; 21(4):415-22. PubMed ID: 19211583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of recombinant human autoantibody fragments directed toward the autoantigenic U1-70K protein.
    Degen WG; Pieffers M; Welin-Henriksson E; van den Hoogen FH; van Venrooij WJ; Raats JM
    Eur J Immunol; 2000 Oct; 30(10):3029-38. PubMed ID: 11069087
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A major B cell epitope present on the apoptotic but not the intact form of the U1-70-kDa ribonucleoprotein autoantigen.
    Greidinger EL; Foecking MF; Magee J; Wilson L; Ranatunga S; Ortmann RA; Hoffman RW
    J Immunol; 2004 Jan; 172(1):709-16. PubMed ID: 14688384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-Sm and anti-RNP antibodies.
    Migliorini P; Baldini C; Rocchi V; Bombardieri S
    Autoimmunity; 2005 Feb; 38(1):47-54. PubMed ID: 15804705
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjögren's syndrome autoantigen-associated RNA.
    Lövgren T; Eloranta ML; Kastner B; Wahren-Herlenius M; Alm GV; Rönnblom L
    Arthritis Rheum; 2006 Jun; 54(6):1917-27. PubMed ID: 16729300
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparison between line immunoassay (LIA) and enzyme-linked immunosorbent assay (ELISA) for the determination of antibodies to extractable nuclear antigenes (ENA) with reference to other laboratory results and clinical features].
    Maclachlan D; Vogt P; Wu X; Rose L; Tyndall A; Hasler P
    Z Rheumatol; 2002 Oct; 61(5):534-44. PubMed ID: 12399881
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.
    Koenig M; Joyal F; Fritzler MJ; Roussin A; Abrahamowicz M; Boire G; Goulet JR; Rich E; Grodzicky T; Raymond Y; Senécal JL
    Arthritis Rheum; 2008 Dec; 58(12):3902-12. PubMed ID: 19035499
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Rheumatic features of Grave's disease in children].
    Chávez-Legaspi M; Ocampo-Campos R; García-Velarde E; Ríos-González J
    Gac Med Mex; 1992; 128(1):35-9. PubMed ID: 1521748
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease.
    Dima A; Jurcut C; Baicus C
    Rheumatol Int; 2018 Jul; 38(7):1169-1178. PubMed ID: 29796907
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autoantibodies in systemic sclerosis.
    Steen VD
    Semin Arthritis Rheum; 2005 Aug; 35(1):35-42. PubMed ID: 16084222
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Photosensitivity in lupus erythematosus.
    Scheinfeld N; Deleo VA
    Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):272-9. PubMed ID: 15379880
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term follow-up of 46 patients with anti-(U1)snRNP antibodies.
    van den Hoogen FH; Spronk PE; Boerbooms AM; Bootsma H; de Rooij DJ; Kallenberg CG; van de Putte LB
    Br J Rheumatol; 1994 Dec; 33(12):1117-20. PubMed ID: 8000737
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High serum levels of antibodies against the recombinant 70 kDa ribonucleoprotein are useful for diagnosing mixed connective tissue disease.
    Salmhofer W; Hermann J; Joch M; Kerl H; Graninger W
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1047-53. PubMed ID: 17714123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Soluble adhesion molecules in pediatric rheumatic diseases.
    Bloom BJ; Miller LC; Blier PR
    J Rheumatol; 2002 Apr; 29(4):832-6. PubMed ID: 11950029
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antinuclear antibodies in the investigation of rheumatic diseases.
    Fritzler MJ
    Bull Rheum Dis; 1985; 35(6):1-10. PubMed ID: 3879803
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.